Ignite Creation Date:
2024-05-06 @ 6:43 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05765604
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-23
First Post:
2023-03-10
Brief Title:
Phase I Clinical Trial of Recombinant COVID-19 Variant Vaccine Sf9 Cell WSK-V102
Sponsor:
WestVac Biopharma Co Ltd
Organization:
WestVac Biopharma Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-14
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-10
First Submit QC Date:
March 10 2023
Study First Post Date:
2023-03-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-22
Last Update Post Date:
2024-04-23
Last Update Post Date Type:
ACTUAL